How is Bioelectrical Impedance used in Neonatal Intensive Care? A Scoping Review

Poor growth and nutrition management in the neonatal period can have a negative impact upon both the short- and long-term outcomes for the infant. Improvements in Bioelectrical Impedance technology and accompanying licencing agreements now make this enhanced device available for use in infants as small as 23 weeks gestational age. An exploration of this technology and its use is now timely. The aim of the scoping review was to answer the question; in preterm and sick term infants in the neonatal intensive care unit, how is Bioelectrical Impedance being utilised, in what situations and when? The scoping review was conducted using the Arksey and O’Malley’s (2005) framework. Results: Forty-nine papers were initially identified and sixteen were included in the scoping review. Three studies were experimental designs, and 13 were observational studies. The review found that BIA was used in neonatal intensive care in three main ways, for 1) fluid status evaluation, 2) as a measure of adequate nutrition and growth, 3) and to validate the technology as an outcome measure in neonates. Conclusions There is a paucity of recent robust research papers which investigate the use of Bioelectrical Impedance in preterm neonates. Available evidence spans a range of 30 years, with technological advancement reducing the application of older studies to the modern neonatal setting. Although this technology may be helpful for decision-making around fluid management and nutrition, in preterm infants, robust evidence is needed to demonstrate the clinical benefit of bioelectrical impedance beyond that of usual care.